Androgenetic alopecia: combining medical and surgical treatments.
BACKGROUND
Medical treatment or surgical reconstruction is used separately to treat androgenetic alopecia. Two drug molecules (5% minoxidil solution and oral finasteride 1 mg) have proven efficacy to stabilize hair loss and promote hair regrowth. Microtransplant of one to three hair follicular unit grafts can provide a definitive hair restoration with a natural appearance.


OBJECTIVE
Aesthetic results can be optimized with a combination of drugs and transplantation of follicular unit grafts. The Dynamic Multifactorial Classification is used to select suitable candidates for this combined approach and also to assess follow-up results.


RESULTS
Dynamic Multifactorial Classification assists the evaluation of the natural history of androgenetic alopecia evolution and also the effects of treatment. Regression of male androgenetic alopecia from Hamilton type V to type III can be achieved by combining drugs with hair grafts.


CONCLUSIONS
Improvement of investigative methods and especially the Dynamic Multifactorial Classification makes it easier for a patient to follow the results of treatment adapted to their case.
Bouhanna
Pierre
P
Center Sabouraud, Hôpital St. Louis, 14 rue Théodore de Banville, 75017 Paris, France. info@bouhanna.com
D000505:Alopecia / Q000188:drug therapy* / Q000601:surgery*; D003131:Combined Modality Therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D018120:Finasteride / Q000627:therapeutic use*; D018859:Hair Follicle / Q000637:transplantation*; D006801:Humans; D008297:Male; D008914:Minoxidil / Q000627:therapeutic use*; D016038:Skin Transplantation / Q000379:methods*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D014665:Vasodilator Agents; D018120:Finasteride; D008914:Minoxidil